Astex reveals partnership with MSD
The partnership will establish small molecule candidates with a view to treating cancer
Read More
Tag: Astex
Cardiff University and Astex in drug discovery collaboration
Partnership will focus on essential new therapies across neurodegenerative diseases
Read More
MSD enlists Otsuka units Taiho and Astex to develop KRAS therapies
KRAS therapies had their break-out moment in 2019, with Amgen’s KRAS inhibitor becoming the first drug of its type to post clinical data last September, demonstrating that it shrank tumors in 90% of lung cancer patients.
Read More
CR UK launches bladder cancer drug trial
Cancer Research UK has launched a new clinical trial of a drug that researchers are hoping could prevent bladder cancers from becoming resistant to chemotherapy.
Read More
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
